Amarin Statistics, Revenue Totals, Facts & News (2022)
Last Updated on: June 3rd, 2021
Here are a few of the most interesting Amarin statistics and facts I was able to dig up including revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Amarin Facts
- Website: Official Website
- Year Founded: 1993
- Headquarters: Dublin, Ireland
- Founder(s): John Therro
- Current Chief Executive: John Therro
What is Amarin?
Amarin Corporation plc is a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health. Amarin’s product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Vascepa® (icosapent ethyl) is Amarin’s first FDA approved product and is available in the United States by prescription. (source)
Amarin Revenue Totals
Amarin annual revenue:
- 2019: $429 million
- 2018: $229 million
- 2017: $181 million
- 2016: $130 million
- 2015: $81 million
Amarin annual net income:
- 2019: $22.645 million net loss
- 2018: $116.445 million net loss
- 2017: $67.865 million net loss
- 2016: $86.350 million net loss
- 2015: $149.059 mllion net loss
Please note that some of these numbers are easier to find than others. A few of these Amarin stats come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.